Un teratógeno que puede cruzar fácilmente la barrera placentaria | 25 JUN 17

Consumo de alcohol durante el embarazo y síndrome alcohólico fetal

Revisión sistemática de la prevalencia del consumo de alcohol en embarazadas y del síndrome alcohólico fetal a nivel global
Autor/a: Svetlana Popova, Shannon Lange, Charlotte Probst, Gerrit Gmel, Jürgen Rehm Lancet Glob Health; Volume 5, No. 3, e290–e299, March 2017
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

Referencias bibliográficas

1 Gell L, Ally A, Buykx P, Hope A, Meier P. Alcohol’s harm to others:an institute of alcohol studies report. Sheffield: Institute of Alcohol Studies, University of Sheffield, 2015.

2 Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life. Am J Epidemiol2002;155: 305–12.

3 Henriksen TB, Hjollund NH, Jensen TK, et al. Alcoholconsumption at the time of conception and spontaneous abortion. Am J Epidemiol2004; 160: 661–67.

4 Albertsen K, Andersen AN, Olsen J, Gronbaek M. Alcoholconsumption during pregnancy and the risk of preterm delivery. Am J Epidemiol2004; 159: 155–61.

5 Kesmodel U, Olsen SF, Secher NJ. Does alcohol increase the risk ofpreterm delivery? Epidemiology 2000; 11: 512–18.

6 Patra J, Bakker R, Irving H, Jaddoe VW, Malini S, Rehm J. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birth weight, preterm birth and small for gestational age (SGA)—a systematic review and meta-analyses. BJOG 2011; 118: 1411–21.

7 Yang Q, Witkiewicz BB, Olney RS, et al.A case-control study ofmaternal alcohol consumption and intrauterine growth retardation. Ann Epidemiol2001; 11: 497–503.

8 O’Callaghan FV, O’Callaghan M, Najman JM, Williams GM, BorW. Maternal alcohol consumption during pregnancy and physicaloutcomes up to 5 years of age: a longitudinal study. Early Hum Dev

2003; 71: 137–48.

9 Chudley A, Conry J, Cook J, et al. Fetal alcohol spectrum disorder:Canadian guidelines for diagnosis. CMAJ 2005; 172: S1–21.

10 Cook JL, Green CR, Lilley CM, et al. Fetal alcohol spectrumdisorder: a guideline for diagnosis across the lifespan. CMAJ 2016;188: 191–97.

11 Stratton K, Howe C, Battaglia F (eds.). Fetal alcohol syndrome:diagnosis, epidemiology, prevention, and treatment. WashingtonDC: Institute of Medicine, 1996.

12 Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders:an overview. Neuropsychol Rev 2011; 21: 73–80.

13 Jones KL, Smith DW. Recognition of the fetal alcohol syndrome inearly infancy.Lancet 1973; 302: 999–1001.

14 Popova S, Lange S, Shield K, et al. Comorbidity of fetal alcoholspectrum disorder: a systematic review and meta-analysis.Lancet 2016; 387: 978–87.

15 WHO. The International Classification of Diseases and relatedhealth problems, 10th revision (ICD-10). Geneva: World HealthOrganization, 2016.

16 Streissguth AP, Barr HM, Kogan J, Bookstein FL. Understandingthe occurrence of secondary disabilities in clients with fetal alcoholsyndrome (FAS) and fetal alcohol effects (FAE). Seattle, WA:

University of Washington, Fetal Alcohol & Drug Unit, 1996.

17 Lupton C, Burd L, Harwood R. Cost of fetal alcohol spectrumdisorders. Am J Med Genet C Semin Med Genet 2004; 127C: 42–50.

18 Popova S, Lange S, Burd L, Rehm J. Economic burden of fetal alcoholspectrum disorder in Canada in 2013.Alcohol Alcohol2016; 51: 367–75.

19 Stade B, Ali A, Bennett D, et al. The burden of prenatal exposure toalcohol: revised measurement of cost, 2007. Can J ClinPharmacol2009; 16: e91–102.

20 Eberhart JK, Parnell SE. The genetics of fetal alcohol spectrum disorders. Alcohol Clin Exp Res 2016; 40: 1154–65.

21 May PA, Gossage JP. Maternal risk factors for fetal alcoholspectrum disorders: not as simple as it might seem.Alcohol Res Health 2011; 34: 15–26.

22 Day J, Savani S, Krempley BD, Nguyen M, Kitlinska JB. Influence of paternal preconception exposures on their off spring: through epigenetics to phenotype. Am J Stem Cells 2016; 5: 11–18.

23 Jonsson E, Salmon A, Warren KR. The international charter onprevention of fetal alcohol spectrum disorder.Lancet Glob Health2014; 2: e135–37.

24 Wong WC, Cheung CS, Hart GJ. Development of a quality assessment tool for systematic reviews of observational studies(QATSO) of HIV prevalence in men having sex with men and associated risk behaviors. Emerge Themes Epidemiology 2008; 5: 23.

25 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.

26 Freeman MF, Tukey JW. Transformations related to the angular andthe square root. Ann Math Stat 1950; 21: 607–11.

27 Cochran WG.The combination of estimates from differentexperiments.Biometrics 1954; 10: 101–29.

28 Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21: 1539–58.

29 Begg CB, Mazumdar M. Operating characteristics of a rankcorrelation test for publication bias. Biometrics 1994; 50: 1088–101.

30 Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysisdetected by a simple, graphical test. BMJ 1997; 315: 629–34.

31 Papke LE, Wooldridge J. Econometric methods for fractionalresponse variables with an application to 401(k) plan participationrates. J Appl Econ 1996; 11: 619–32.

32 World Bank.World development indicators. Washington, DC:World Bank, 2014.

33 WHO. Global information system on alcohol and health (GISAH).Geneva: World Health Organization, 2014.

34 R Development Core Team. R: a language and environment forstatistical computing. Vienna: R Foundation for StatisticalComputing, 2015.

35 Munn Z, Moola S, Riitano D, Lisy K. The development of a criticalappraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag2014; 3: 123–28.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023